GLOBEALERT
HEALTH● LOWJun 17 · Jun 17, 2026, 12:45 PM

IceCure Reports 70 % Growth in Active U . S . Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance

prnewswire.com · United States

IceCure has reported substantial growth in its active commercial installations for breast cancer cryoablation within the U.S. market. This follows the treatment's clearance by the FDA, indicating increased adoption of the medical procedure.

GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.

More from United States

More in Health